AWK vs GANX · P/E 22, rev $4.65B vs rev $55.2K
American Water Works (AWK) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported GANX revenue for 2023-12-31 was $55.2K. Net income was -$22.3M. Revenue was down 60.6% from 2022-12-31 to 2023-12-31. GANX currently screens at market cap $53.0M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. GANX currently screens at market cap $53.0M.
Not investment advice. Open the AWK and GANX stock pages for the full models.
Not investment advice.